Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent

Angiogenesis is an essential process in tumor growth, invasion and metastasis. VEGF receptor 2 (VEGFR2) inhibitors targeting tumor angiogenic pathway have been widely used in the clinical cancer treatment. However, most of currently used VEGFR2 kinase inhibitors are multi-target inhibitors which mig...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zongru, Wang, Li, Liu, Xuesong, Chen, Cheng, Wang, Beilei, Wang, Wenliang, Hu, Chen, Yu, Kailin, Qi, Ziping, Liu, Qingwang, Wang, Aoli, Liu, Jing, Hong, Guangchen, Wang, Wenchao, Liu, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049616/
https://www.ncbi.nlm.nih.gov/pubmed/32140394
http://dx.doi.org/10.1016/j.apsb.2019.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049616/
https://www.ncbi.nlm.nih.gov/pubmed/32140394
http://dx.doi.org/10.1016/j.apsb.2019.10.004

Ejemplares similares